InvestorsObserver
×
News Home

What is the Market's View on Passage Bio Inc (PASG) Stock's Price and Volume Trends Tuesday?

Tuesday, March 19, 2024 01:48 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Passage Bio Inc (PASG) Stock's Price and Volume Trends Tuesday?

Passage Bio Inc (PASG) stock is higher by 14.18% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Passage Bio Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PASG!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With PASG Stock Today?

Passage Bio Inc (PASG) stock is trading at $1.53 as of 1:33 PM on Tuesday, Mar 19, an increase of $0.07, or 4.79% from the previous closing price of $1.46. Volume today is elevated. So far 3,296,608 shares have traded compared to average volume of 337,066 shares. The stock has traded between $1.42 and $1.69 so far today. To screen for more stocks like Passage Bio Inc click here.

More About Passage Bio Inc

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Click Here to get the full Stock Report for Passage Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App